[Skip to Content]
Pulmonary Hypertension
What is PH?
Primary PH
Isolated PH
Secondary PH
Exercised Induced PH
Causes of PH
PH Disease Correlations
Symptoms
Diagnosis
Prognosis
Treatments
Research Registries
Research
Patient Support Organizations
Personal Stories

Research Registries for Pulmonary Hypertension

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer
PH Research Panel (by WWMR)
PH Registry of Scleroderma (PHAROS)
REVEAL Registry for PH
SureSteps Patient Support Program
Scleroderma Research Registries

Pulmonary Support Organizations

Pulmonary Hypertension Research Panel in U.S. — Qualified participants will earn $50.00, plus opportunity to earn more!

WWMR a Division of IntrisiQ, LLC logoWWMR, a division of IntrinsiQ, is searching for patients diagnosed with PAH or their caregivers to serve on their research panel. Qualified participants will earn $50.00, plus the opportunity to earn more money by participating in future research studies. Participants must either be diagnosed with PAH, or be a caregiver for someone living with PAH. To learn more, and to see if you qualify, call WWMR toll free at 1-888-947-2339 and select option 4, or email PAH_Panel@wwmr.com. (Also see: ISN Newsletter: Do you have PAH?)

Pulmonary Hypertension Registry of Scleroderma (PHAROS)

pharosPulmonary Hypertension Registry of Scleroderma (PHAROS) is a multicenter study of systemic scleroderma (systemic sclerosis) patients in the United States who are at high risk for developing pulmonary hypertension as well as those with newly diagnosed with pulmonary hypertension, by members of the Scleroderma Clinical Trial Consortium (SCTC). Posted 04-10-06. (Also see: PHAROS)
Overview of Research Registries
Overview of PHAROS Registry
Outcomes of PHAROS
How to Enroll
Related Links

REVEAL (Registry to Evaluate Early And Long-term PAH Disease Management)

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH (Pulmonary Arterial Hypertension) Disease Management. The REVEAL Registry will provide investigators with descriptive data regarding the clinical course and treatment outcomes in patients with WHO (World Health Organization) Group I PAH. Data derived from the study may offer important tools for assessing current management practices of treating investigators, as well as changes over time. This study is ongoing, but not recruiting participants. December 2009.

SureSteps Patient Support Program for Tracleer/Bosentan Patients

SureSteps™ is a free patient support program for people who are on Tracleer/Bosentan.

Actelion Pharmaceuticals US, Inc. is pleased to announce the launch of Sure StepsTM, a comprehensive support program for U.S. patients enrolled in the Tracleer Access Program (T.A.P.). Sure StepsTM free services include one-to-one attention from a Nurse Counselor. Posted 11-08-06.
Sclero Forums by the International Scleroderma NetworkBosentan For The Treatment Of Scleroderma. Includes comments about SureSteps™ program. Discussion started 12-02-06. Sclero Forums.

Scleroderma Research Registries

Overview of Research Registries
Registries for Rheumatic Diseases
Scleroderma Experts
Pulmonary Hypertension Registry
Twins/Close Siblings Autoimmune
U.K. Scleroderma Registries
U.S./Canada Scleroderma Registries

Pulmonary Support Organizations

Pulmonary Support Resources ISN.
The American Lung Association and Myogen Announce Pulmonary Arterial Hypertension (PAH) Educational Partnership. They will collaborate on a new public awareness initiative to educate the public about PAH, a progressive and life-threatening disease that affects an estimated 200,000 patients worldwide. WebWire. American Lung Assoc. 09/06/06.
 
Go to Pulmonary Hypertension Research
 
  1. Post a message in Sclero Forums
  2. Email: isn@sclero.org
  3. English Email Form
  4. Español Email Form
  5. Italiano Email Form
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
United States
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
Scleroderma Hotline
Toll Free U.S. 1-800-564-7099
Direct Line: 1-952-831-3091

For languages other than English, please email isn@sclero.org.